Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.497

-6.3%

2:33 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (30)	5/3/2000 11:25:00 AM
From: polar bear	Read Replies (1) of 368

How does Sangomo's IP compare with "Gendaq"'s???? I bought into Sangamo at $7.5 and like the way it has grown since then! I appreciate Zinc fingers and their potential utility as regulators of gene expression. However, I was reading my copy of BioWorld International today and noticed an article about a London company founded by Aaron Klug called "Gendaq, Ltd.". They appear to also be working on gene regulation through zinc finger motifs. What I really want to know is how do the relative IP positions of this Gendaq company and Sangamo compare? Did Sangamo address this in their IPO filings? Does anyone want to comment? Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next